Background: To screen and validate novel stool protein biomarkers of colorectal cancer (CRC).
Methods: A novel aptamer-based screen of 1317 proteins was used to uncover elevated proteins in the stool of patients with CRC, as compared to healthy controls (HCs) in a discovery cohort. Selected biomarker candidates from the discovery cohort were ELISA validated in three independent cross-sectional cohorts comprises 76 CRC patients, 15 adenoma patients, and 63 healthy controls, from two different ethnicities.
IEEE Trans Med Imaging
October 2021
Computer-aided diagnosis (CAD) systems must constantly cope with the perpetual changes in data distribution caused by different sensing technologies, imaging protocols, and patient populations. Adapting these systems to new domains often requires significant amounts of labeled data for re-training. This process is labor-intensive and time-consuming.
View Article and Find Full Text PDFIEEE J Biomed Health Inform
February 2021
The kidney biopsy based diagnosis of Lupus Nephritis (LN) is characterized by low inter-observer agreement, with misdiagnosis being associated with increased patient morbidity and mortality. Although various Computer Aided Diagnosis (CAD) systems have been developed for other nephrohistopathological applications, little has been done to accurately classify kidneys based on their kidney level Lupus Glomerulonephritis (LGN) scores. The successful implementation of CAD systems has also been hindered by the diagnosing physician's perceived classifier strengths and weaknesses, which has been shown to have a negative effect on patient outcomes.
View Article and Find Full Text PDFArtificial intelligence (AI) for the purpose of this review is an umbrella term for technologies emulating a nephropathologist's ability to extract information on diagnosis, prognosis, and therapy responsiveness from native or transplant kidney biopsies. Although AI can be used to analyze a wide variety of biopsy-related data, this review focuses on whole slide images traditionally used in nephropathology. AI applications in nephropathology have recently become available through several advancing technologies, including (i) widespread introduction of glass slide scanners, (ii) data servers in pathology departments worldwide, and (iii) through greatly improved computer hardware to enable AI training.
View Article and Find Full Text PDFBackground: Alzheimer's disease (AD) is projected to become one of the most expensive diseases in modern history, and yet diagnostic uncertainties exist that can only be confirmed by postmortem brain examination. Machine Learning (ML) algorithms have been proposed as a feasible alternative to the diagnosis of several neurological diseases and disorders, such as AD. An ideal ML-derived diagnosis should be inexpensive and noninvasive while retaining the accuracy and versatility that make ML techniques desirable for medical applications.
View Article and Find Full Text PDF